↓ Skip to main content

Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma

Overview of attention for article published in American Journal of Health-System Pharmacy, February 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

policy
1 policy source
twitter
20 X users
patent
2 patents

Readers on

mendeley
113 Mendeley